One-Year Follow-up Safety Study in Subjects Previously Implanted With VC-01™

ViaCyte51 enrolled

Overview

The purpose of this trial is to evaluate the long-term safety in subjects previously implanted with VC-01™ combination product.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Type 1 Diabetes Mellitus

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Previous implantation of VC-01™ combination product with subsequent explantation of all VC-01 units. Exclusion Criteria: * There are no exclusion criteria for this trial.

Outcomes

Primary Outcomes

Incidence of adverse events reported during the study.

Time frame: 12 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.